Aslihan Gerhold-Ay
Overview
Explore the profile of Aslihan Gerhold-Ay including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
561
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Manitz J, Gerhold-Ay A, Kieslich P, Shah P, Mrowiec T, Tyroller K
Cancer Med
. 2024 Jun;
13(12):e7411.
PMID: 38924353
Background: Avelumab first-line (1 L) maintenance is a standard of care for advanced urothelial carcinoma (aUC) based on the JAVELIN Bladder 100 phase 3 trial, which showed that avelumab 1 ...
2.
Bonnemaijer P, van Leeuwen E, Iglesias A, Gharahkhani P, Vitart V, Khawaja A, et al.
Commun Biol
. 2019 Dec;
2:435.
PMID: 31798171
A new avenue of mining published genome-wide association studies includes the joint analysis of related traits. The power of this approach depends on the genetic correlation of traits, which reflects...
3.
Keller K, Tesche C, Gerhold-Ay A, Nickels S, Klok F, Rappold L, et al.
J Thromb Haemost
. 2019 Jul;
17(11):1923-1934.
PMID: 31344319
Background: While the importance of patients' quality of life (QoL) in chronic cardiac or pulmonary disease is uncontroversial, the burden of an acute pulmonary embolism (PE) on QoL has received...
4.
Stelzer A, Maccioni L, Gerhold-Ay A, Smedby K, Schumacher M, Nieters A, et al.
BMC Med Genet
. 2019 Jul;
20(1):128.
PMID: 31324155
Background: Increasingly, molecular measurements from multiple studies are pooled to identify risk scores, with only partial overlap of measurements available from different studies. Univariate analyses of such markers have routinely...
5.
Keller K, Rappold L, Gerhold-Ay A, Hobohm L, Hasenfuss G, Konstantinides S, et al.
Thromb Res
. 2019 May;
178:173-181.
PMID: 31039477
Introduction: Sex-specific differences regarding risk factors, symptoms and prognosis have been reported for several cardiovascular diseases. For patients with pulmonary embolism (PE), sex-specific data are limited and inconsistent. We aimed...
6.
Gomez R, Schorsch M, Gerhold-Ay A, Hasenburg A, Seufert R, Skala C
Geburtshilfe Frauenheilkd
. 2019 Jan;
79(1):72-78.
PMID: 30686836
For patients considering undergoing assisted reproductive techniques (ART), many concerns arise when persistent ovarian cysts are found. This large study aimed to determine how ovarian cyst removal affects success rates...
7.
Goesswein D, Habtemichael N, Gerhold-Ay A, Mazur J, Wunsch D, Knauer S, et al.
Sci Rep
. 2018 May;
8(1):7326.
PMID: 29743718
Head and neck squamous cell carcinoma (HNSCC) often metastasize to lymph nodes resulting in poor prognosis for patients. Unfortunately, the underlying molecular mechanisms contributing to tumour aggressiveness, recurrences, and metastasis...
8.
Foerster F, Hess M, Gerhold-Ay A, Marquardt J, Becker D, Galle P, et al.
Sci Rep
. 2018 Mar;
8(1):5351.
PMID: 29599491
The general relevance of the immune system for cancer development and therapy is increasingly recognized. However and although the immune contexture of most human cancer types has been determined, a...
9.
Schmidt M, Weyer-Elberich V, Hengstler J, Heimes A, Almstedt K, Gerhold-Ay A, et al.
Breast Cancer Res
. 2018 Feb;
20(1):15.
PMID: 29482642
Background: The clinical importance of tumor-infiltrating cluster of differentiation 4 (CD4) T cells is incompletely understood in early breast cancer. We investigated the clinical significance of CD4, forkhead box P3...
10.
Paret C, Theruvath J, Russo A, Kron B, El Malki K, Lehmann N, et al.
Oncotarget
. 2016 Nov;
7(50):83378-83391.
PMID: 27825128
High grade neuroepithelial tumor of the central nervous system with BCOR alteration (CNS HGNET-BCOR) is a recently described new tumor entity with a dismal prognosis. The objective of this study...